Immunoassay Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Oct 2023 Pages: 166 SKU: IRTNTR71646

Immunoassay Market Forecast 2024-2028

The global immunoassay market is projected to reach a value of USD 8.64 billion with CAGR of 4.42% between 2023 and 2028. The Rising geriatric population drives market growth, attributed to improved living standards and healthcare, leading to longer life expectancies. This demographic shift results in increased prevalence of chronic diseases and age-related illnesses, such as cancer and autoimmune disorders. Immunoassays play a crucial role in identifying genetic risk factors for diseases, aiding in targeted screening and prevention.

With a growing demand for immunoassays in combating chronic diseases, it becomes a key driver for global market growth. The application of immunoassays in food safety, particularly in detecting antibiotic residues, is a prominent trend, enhancing market prospects and forecasting. Immunoassay optimization ensures specificity, accuracy, precision, and reliability in results.

Immunoassay Market Share

For More Highlights About this Report, Download Free Sample in a Minute 

Immunoassay Market Segmentations

The product segment includes reagents, kits, and analyzers. The technology segment includes ELISA, radioimmunoassay (RIA), ELISpot and others. The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW).

Product Segment

The market share growth by the reagents and kits segment will be significant during the forecast period. Reagents are an indispensable part of any chemical reaction. A reagent is a substance or compound that facilitates a reaction and is widely used in testing. Reagents are an important part of immunoassays. Reagents are designed to help solve difficult technical problems such as nonspecific binding and background interference. They optimize immunoassays and help to solve technical problems.

Get a glance at the market contribution of various segments Download the PDF Sample

The reagents and kits segment was valued at USD 21.89 billion in 2018. Reagents help stabilize an antigen or antibody over time while blocking interferences that may impact the accuracy of the immunoassay. Moreover, the reagent formulation needs to be compatible with analyzer materials to prevent any damage to the analyzer component. Assay kits can be convenient, time-saving tools to help accelerate research, but not all assays are created equal. Some that promise convenience fail to deliver the biologically relevant sensitivity or reproducibility needed for long-term studies. This can lead to more time and money in the end.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The rapid growth of the elderly population, the high incidence of chronic and infectious diseases, and the growing awareness among the people have led people to conduct regular health checks and tests, which increases the demand for immunoassays in the region.

Furthermore, all major companies are mainly focusing on the US as a market by launching products to increase their market share. Moreover, the increasing prevalence of chronic diseases such as cancer is expected to contribute to the high demand for immunoassays in the region. Hence, such factors are expected to drive the growth of the immunoassay market in the region during the forecast period.

Market Dynamics and Customer Landscape

The Immunoassay Market is driven by advancements in the geriatric population and Immunochemistry, rising with techniques such as Radioimmunoassays and Immunofluorescence assays leading the way. Lateral flow assays and Allergy testing are witnessing increased demand due to their rapid results and ease of use. Therapeutic drug monitoring and Immunosuppressant assays are crucial for personalized medicine, driving market growth.

Trends in the market include Immunoassay automation and optimization, enhancing efficiency and reproducibility. Ensuring specificity, accuracy, and precision remains paramount, with ongoing efforts to improve reliability.

Challenges include the need for continuous market research and growth analysis to stay abreast of evolving technologies and market dynamics. Market reports and forecasting play a vital role in strategic decision-making for stakeholders.

Overall, the Immunoassay Market is poised for significant growth, fueled by innovation, expanding applications, and the continuous quest for improved diagnostic accuracy and efficiency.

Key Market Driver

The rising geriatric population is the key factor driving market growthThe global geriatric population has increased steadily in recent years across the globe. This demographic shift is largely due to improved living standards and health care, leading to longer life expectancies. There is an increased prevalence of chronic diseases and age-related illnesses, such as cancer, autoimmune disorders, and infectious diseases. The geriatric population is highly susceptible to various age-related diseases, such as cardiovascular diseases, cancer, neurodegenerative disorders, and chronic conditions like diabetes.

Furthermore, immunoassays enable the identification of the genetic risk factors for certain diseases, enabling targeted screening and preventive measures. Given the increasing prevalence of chronic diseases in the geriatric population, the demand for immunoassays is expected to continue to grow, making it a significant driver for the growth of the global immunoassay market during the forecast period. 

Significant Market Trends

The application of immunoassays in the food and beverage industry is the primary trend shaping market growthAntibiotics are mainly used to prevent and treat diseases in livestock. Thus, remaining antibiotic residues in foods of animal origin are harmful to humans and their health. Food contamination due to antibiotic residues has become a major problem globally due to the massive and uncontrolled use of antibiotics.

Furthermore, immunoassay is a promising method in the evaluation of food and environmental protection. It is a biochemical process based on the specific antigen-antibody interaction. These assays require simple sample preparation and offer highly sensitive detection for the screening of antibiotic residues. Hence, the rising application of immunoassays in food testing will drive the growth of the market during the forecast period.

Major Market Challenge

Inadequate medical reimbursements is a challenge that affects market growthBecause modern immunoassay products are so expensive, medical reimbursement is important for patients undergoing such tests. As a result, limited reimbursement has hindered the adoption of these modern devices. In the US, the Centers for Medicare and Medicaid Services (CMS) reimburses certain diagnostic test kit products. Many private and government initiative centers offer reimbursement facilities around the world.

In addition, reimbursement structures in the US and European countries are influenced by the existing high healthcare costs and increased demand for treatment. The global immunoassay market does not have reimbursements for costly diagnostic practices. Fair reimbursement systems for immunoassays and molecular diagnostic methods are crucial for accurate diagnosis, the absence of which may restrict the market growth during the forecast period.

Market Analyst Overview

In the realm of Medical technology and the Healthcare industry, Immunoassay plays a pivotal role, offering advanced Diagnostic testing solutions. Leveraging innovative Laboratory equipment and Diagnostic assays, it enables precise Biomarker detection through Antibody-based assays and other analytical methods.

From Clinical diagnostics to Point-of-care testing, immunoassay techniques such as Enzyme-linked immunosorbent assay (ELISA) and Rapid diagnostic tests expedite diagnosis. Fluorescence immunoassays and Chemiluminescent immunoassays enhance sensitivity in detecting various conditions, while Multiplex assays provide comprehensive insights.

Immunoassay kits and Diagnostic reagents empower researchers and clinicians with tools for accurate analysis. Emerging technologies like Biosensors and Microfluidic devices further improve Protein detection and Hormone assays.

With applications in Infectious disease testing, Cancer biomarkers, and Autoimmune disease testing, immunoassay contributes to Precision medicine. Immunoassay platforms streamline operations in Clinical laboratories and Research laboratories, driving Market forecasting and market growth analysis.

Continuous advancements in Assay development and Immunoassay validation ensure Clinical chemistry excellence. Automation and optimization enhance Immunoassay sensitivity and specificity, fostering Biomarker discovery and improving Immunoassay performance in terms of accuracy, precision, and reliability.

Key Companies in Immunoassay Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers immunoassays such as Alinity.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Abnova Corp.
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bio Techne Corp.
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Mindray Bio medical Electronics Co. Ltd.
  • Omega Diagnostics Group Plc
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Quidelortho Corp.
  • Seramun Diagnostica GmbH
  • Siemens AG
  • Sysmex Corp.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Immunoassay Market Scope

Report Coverage

Details

Page number

166

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 4.42%

Market growth 2024-2028

USD 8.64 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.49

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Becton Dickinson and Co., Bio Techne Corp., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Mindray Bio medical Electronics Co. Ltd., Omega Diagnostics Group Plc, OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quidelortho Corp., Seramun Diagnostica GmbH, Siemens AG, Sysmex Corp., Tecan Trading AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, market growth and forecasting, inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Immunoassay Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2024 and 2028
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global immunoassay market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global immunoassay market 2018 - 2022 ($ billion)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
    • 4.3 Technology Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Technology Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Reagents and kits - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Reagents and kits - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2023-2028 (%)
    • 6.4 Analyzers - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Analyzers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Analyzers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Analyzers - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Analyzers - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by Technology

    • 7.1 Market segments
      • Exhibit 44: Chart on Technology - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Technology - Market share 2023-2028 (%)
    • 7.2 Comparison by Technology
      • Exhibit 46: Chart on Comparison by Technology
      • Exhibit 47: Data Table on Comparison by Technology
    • 7.3 ELISA - Market size and forecast 2023-2028
      • Exhibit 48: Chart on ELISA - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on ELISA - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on ELISA - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on ELISA - Year-over-year growth 2023-2028 (%)
    • 7.4 Radioimmunoassay (RIA) - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Radioimmunoassay (RIA) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Radioimmunoassay (RIA) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Radioimmunoassay (RIA) - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Radioimmunoassay (RIA) - Year-over-year growth 2023-2028 (%)
    • 7.5 ELISpot and others - Market size and forecast 2023-2028
      • Exhibit 56: Chart on ELISpot and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on ELISpot and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on ELISpot and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on ELISpot and others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by Technology
      • Exhibit 60: Market opportunity by Technology ($ billion)
      • Exhibit 61: Data Table on Market opportunity by Technology ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 Canada - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.11 Germany - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ billion)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 111: Abbott Laboratories - Overview
              • Exhibit 112: Abbott Laboratories - Business segments
              • Exhibit 113: Abbott Laboratories - Key news
              • Exhibit 114: Abbott Laboratories - Key offerings
              • Exhibit 115: Abbott Laboratories - Segment focus
            • 12.4 Abnova Corp.
              • Exhibit 116: Abnova Corp. - Overview
              • Exhibit 117: Abnova Corp. - Product / Service
              • Exhibit 118: Abnova Corp. - Key offerings
            • 12.5 Agilent Technologies Inc.
              • Exhibit 119: Agilent Technologies Inc. - Overview
              • Exhibit 120: Agilent Technologies Inc. - Business segments
              • Exhibit 121: Agilent Technologies Inc. - Key offerings
              • Exhibit 122: Agilent Technologies Inc. - Segment focus
            • 12.6 Becton Dickinson and Co.
              • Exhibit 123: Becton Dickinson and Co. - Overview
              • Exhibit 124: Becton Dickinson and Co. - Business segments
              • Exhibit 125: Becton Dickinson and Co. - Key news
              • Exhibit 126: Becton Dickinson and Co. - Key offerings
              • Exhibit 127: Becton Dickinson and Co. - Segment focus
            • 12.7 Bio Techne Corp.
              • Exhibit 128: Bio Techne Corp. - Overview
              • Exhibit 129: Bio Techne Corp. - Business segments
              • Exhibit 130: Bio Techne Corp. - Key offerings
              • Exhibit 131: Bio Techne Corp. - Segment focus
            • 12.8 bioMerieux SA
              • Exhibit 132: bioMerieux SA - Overview
              • Exhibit 133: bioMerieux SA - Product / Service
              • Exhibit 134: bioMerieux SA - Key offerings
            • 12.9 Danaher Corp.
              • Exhibit 135: Danaher Corp. - Overview
              • Exhibit 136: Danaher Corp. - Business segments
              • Exhibit 137: Danaher Corp. - Key news
              • Exhibit 138: Danaher Corp. - Key offerings
              • Exhibit 139: Danaher Corp. - Segment focus
            • 12.10 DiaSorin SpA
              • Exhibit 140: DiaSorin SpA - Overview
              • Exhibit 141: DiaSorin SpA - Business segments
              • Exhibit 142: DiaSorin SpA - Key news
              • Exhibit 143: DiaSorin SpA - Key offerings
              • Exhibit 144: DiaSorin SpA - Segment focus
            • 12.11 F. Hoffmann La Roche Ltd.
              • Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.12 Mindray Bio medical Electronics Co. Ltd.
              • Exhibit 150: Mindray Bio medical Electronics Co. Ltd. - Overview
              • Exhibit 151: Mindray Bio medical Electronics Co. Ltd. - Product / Service
              • Exhibit 152: Mindray Bio medical Electronics Co. Ltd. - Key offerings
            • 12.13 OraSure Technologies Inc.
              • Exhibit 153: OraSure Technologies Inc. - Overview
              • Exhibit 154: OraSure Technologies Inc. - Business segments
              • Exhibit 155: OraSure Technologies Inc. - Key offerings
              • Exhibit 156: OraSure Technologies Inc. - Segment focus
            • 12.14 PerkinElmer Inc.
              • Exhibit 157: PerkinElmer Inc. - Overview
              • Exhibit 158: PerkinElmer Inc. - Business segments
              • Exhibit 159: PerkinElmer Inc. - Key news
              • Exhibit 160: PerkinElmer Inc. - Key offerings
              • Exhibit 161: PerkinElmer Inc. - Segment focus
            • 12.15 Siemens AG
              • Exhibit 162: Siemens AG - Overview
              • Exhibit 163: Siemens AG - Business segments
              • Exhibit 164: Siemens AG - Key news
              • Exhibit 165: Siemens AG - Key offerings
              • Exhibit 166: Siemens AG - Segment focus
            • 12.16 Tecan Trading AG
              • Exhibit 167: Tecan Trading AG - Overview
              • Exhibit 168: Tecan Trading AG - Business segments
              • Exhibit 169: Tecan Trading AG - Key offerings
              • Exhibit 170: Tecan Trading AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 171: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 173: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 176: Inclusions checklist
                • Exhibit 177: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 178: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 179: Research methodology
                • Exhibit 180: Validation techniques employed for market sizing
                • Exhibit 181: Information sources
              • 13.5 List of abbreviations
                • Exhibit 182: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              immunoassay market market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis